企業プロフィール
Kodiak Sciences 株価・ニュース・カタリスト
- ティッカー:
- KOD
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
37.22 USD (-2.90%)
終値
最終更新: 2026年8月24日
2.08B USD
時価総額
株価変動の要因
As of Aug 24, 2026, KOD closed down 2.90% at $37.22. No new same-company headline was identified in the current news window.
企業概要
事業概要
Kodiak Sciences is a retinal-disease company focused on ophthalmology and long-duration eye therapies. Its story has been shaped by the challenge of building a differentiated retina franchise.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Kodiak sits in specialty ophthalmology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, delivery strategy, and the ability to create a durable retinal-disease platform.
バイオ業界での位置付け
Kodiak is a high-beta eye-care name with strong sensitivity to data and execution risk.
今後のカタリスト
- Kodiak is now mostly a legacy and transaction-closeout name, so the catalysts are any final ophthalmology or strategic milestones that clarify remaining value. The market is not treating it like a fresh growth story anymore.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。